Stockscreener 앱 받기
1.83
6.63%
-0.13
시간 외 거래:
1.80
-0.03
-1.64%
전일 마감가:
$1.96
열려 있는:
$1.97
하루 거래량:
716.30K
Relative Volume:
0.61
시가총액:
$57.56M
수익:
-
순이익/손실:
$-69.00M
주가수익비율:
-0.6583
EPS:
-2.78
순현금흐름:
$-55.26M
1주 성능:
-4.19%
1개월 성능:
+12.27%
6개월 성능:
+19.61%
1년 성능:
-73.78%
1일 변동 폭
$1.82
$2.01
1주일 범위
$1.82
$2.02
52주 변동 폭
$1.05
$8.74
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
명칭
Acrivon Therapeutics Inc
전화
617-207-8979
주소
480 ARSENAL WAY, SUITE 100, WATERTOWN
ACRV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.83 | 61.65M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 재개 | Piper Sandler | Overweight |
| 2025-01-31 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | 개시 | JMP Securities | Mkt Outperform |
| 2023-12-15 | 재개 | Jefferies | Buy |
| 2023-10-05 | 개시 | Maxim Group | Buy |
| 2023-06-02 | 개시 | Oppenheimer | Outperform |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-04-27 | 개시 | Ladenburg Thalmann | Buy |
| 2023-04-20 | 개시 | H.C. Wainwright | Buy |
| 2022-12-12 | 개시 | Cowen | Outperform |
| 2022-12-12 | 개시 | Jefferies | Buy |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
모두보기
Acrivon Therapeutics Inc 주식(ACRV)의 최신 뉴스
News impact scoring models applied to Acrivon Therapeutics Inc.July 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - newser.com
How Acrivon Therapeutics Inc. stock valuations compare to rivalsMarket Performance Recap & Daily Technical Stock Forecast Reports - newser.com
What Fibonacci levels say about Acrivon Therapeutics Inc. reboundPortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
Is Acrivon Therapeutics Inc. stock positioned well for digital economyPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Acrivon Therapeutics (NASDAQ:ACRV) Given "Sell (E+)" Rating at Weiss Ratings - MarketBeat
Sector ETF performance correlation with Acrivon Therapeutics Inc.July 2025 PreEarnings & Long-Term Investment Growth Plans - newser.com
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates - 富途牛牛
Risk vs reward if holding onto Acrivon Therapeutics Inc.July 2025 Market Mood & Safe Entry Trade Reports - newser.com
Will Acrivon Therapeutics Inc. stock benefit from sector rotationInflation Watch & Fast Entry Momentum Alerts - newser.com
What to expect from Acrivon Therapeutics Inc. in the next 30 daysJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Short Interest in Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Rises By 127.8% - Defense World
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Short Interest Up 127.8% in September - MarketBeat
Spotlight On 3 Promising Penny Stocks With Over $50M Market Cap - simplywall.st
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
225,000 Stock Options: Biotech Acrivon Therapeutics Awards Major Inducement Grant to Key New Hire - Stock Titan
Acrivon Therapeutics, Inc. $ACRV Holdings Decreased by Goldman Sachs Group Inc. - Defense World
Brokerages Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $15.00 - Defense World
Tools to assess Acrivon Therapeutics Inc.’s risk profileTreasury Yields & Stepwise Trade Signal Guides - newser.com
Acrivon Therapeutics Inc (ACRV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acrivon Therapeutics Inc 주식 (ACRV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
May 01 '25 |
Sale |
1.34 |
298,886 |
400,507 |
3,104,139 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 25 '25 |
Sale |
1.95 |
1,054,669 |
2,056,605 |
4,306,189 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 29 '25 |
Sale |
1.41 |
250,000 |
352,500 |
3,840,906 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 28 '25 |
Sale |
1.56 |
215,283 |
335,841 |
4,090,906 |
5.74%
자본화:
|
볼륨(24시간):